https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/aoci https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/bankruptcy-claims-amount-of-claims-filed https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/buybacks-payments-for-repurchase-of-equity https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cash https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cash-change https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/cumulative-effect-on-retained-earnings-net-of-tax https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-fee-amount https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/debtor-reorganization-items-write-off-of-deferred-financing-costs-and-debt-discounts https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-subject-to-expiration https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/effect-of-exchange-rate-on-cash https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/goodwill-acquired https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/interest-and-debt-expense https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/liabilities-subject-to-compromise https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/liabilities-subject-to-compromise-other-liabilities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/net-income https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-shares-issued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-impairment-loss https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/other-employee-related-liabilities-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/other-income https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/paid-in-capital-share-based-compensation-employee-stock-purchase-program-requisite-service-period-recognition https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/preferred-stock-dividends-per-share-declared https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/proceeds-from-issuance-of-commercial-paper https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/public-float https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/reorganization-items https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/restricted-cash-current https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/restructuring-and-related-cost-expected-number-of-positions-eliminated https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/restructuring-costs https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/revenue https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-option-plan-expense https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-grants-in-period-grant-date-intrinsic-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-number-of-shares-change https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/sublease-income https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/sienna-biopharmaceuticals-inc/write-off-of-deferred-debt-issuance-cost